Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Complain Constructively: It’s Called Advocacy

Belinda Birnbaum, MD  |  Issue: June 2023  |  May 8, 2023

I joined the ACR’s Government Affairs Committee (GAC). The committee develops and reviews policies most important to rheumatologists and our patients. We work to change payer and PBM policies regarding step therapy and nefarious co-pay accumulator programs, which are increasingly used by insurance companies to prevent copay assistance from counting toward a patient’s deductible or out-of-pocket maximum.

We also take our complaints to Capitol Hill twice a year to address our concerns. As doctors, we can offer unique insights into day-to-day practice and educate those responsible for the law that affects us. One could say we spend the day complaining, but we are speaking out against practices and policies that are unjust and harmful, and educating lawmakers about these challenges—in other words, we are advocating. Learning about these issues—even those that did not personally affect me—and working in the company of others dedicated to improving our field and our patients is inspiring.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Positive Outlets

Now, when a patient has trouble accessing medication, I don’t shrug and commiserate over the state of our country’s medical system—I encourage them to call their representatives to share their stories. I am surprised at how many people respond positively to this suggestion. Every one of us has a voice, and we should use them.

It is a privilege to care for our patients and work toward change. So here is my challenge to other ACR/ARP members: The next time you are frustrated, combat that feeling with advocacy and let me know how you feel afterward. Don’t get me wrong; I still complain. But I do try to minimize it (and do it out of my kids’ earshot). And I look for positive outlets for my complaints. this past spring, I wrote an op-ed about the effect the Dobbs v. Jackson Women’s Health decision will have on our rheumatology patients. My now 15-year-old cut it out and framed it for me.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Anyone who can complain can advocate. That is each of us.

Here are some suggestions:

  • Call your legislators and review your concerns about Medicare reimbursements, the cost of copays and telemedicine coverage. They do want to hear from us.
  • Donate to RheumPAC—any amount helps.
  • Make sure you are registered to vote—doctors are 9% less likely to vote than the general population.
  • Join Vot-ER, wear a badge and encourage your patients to vote.
  • Tell the ACR about your concerns. We want to hear from you.
  • Learn more about advocacy in the upcoming Advocacy 101.

Belinda Birnbaum, MD, is a rheumatologist at Bryn Mawr Medical Specialists Association in Pennsylvania and a member of the ACR Government Affairs Committee.

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & AdvocacyProfiles Tagged with:AdvocacyBelinda BirnbaumGovernment Affairs Committee (GAC)

Related Articles

    Every Vote Counts

    September 11, 2020

    It came down to the toss of a coin. David Yancey represented the Newport News district in the Virginia House of Delegates beginning in 2011. In 2017, he had a challenger. Shelly Simonds, a member of the local school board, decided to run for the privilege of representing the 94th District. The final tally: 11,608…

    New ACR/ARP Committee Members Are Ready to Work

    January 16, 2020

    Volunteering is a great way to give back and can be truly meaningful. Myriad worthwhile causes exist, so it can be hard to choose among them, but donating time to ACR and ARP committees helps promote rheumatology practice and brings awareness to rheumatic diseases. The College relies on volunteers to help achieve strategic priorities, promote…

    Diagnosis Can Be Elusive for Fever of Unknown Origin

    Diagnosis Can Be Elusive for Fever of Unknown Origin

    March 15, 2016

    Settling into room 501 at Maine Medical Center, Mrs. N was on her way to the bathroom when she felt it coming on. One moment she was okay; the next, her chest felt damp and cold, even as her face flushed and her temperature spiked. Her forehead glistened beads of warm sweat. She felt the…

    Your Representatives on Capitol Hill

    March 1, 2007

    Government Affairs Committee advocates on behalf of the ACR and all rheumatologists

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences